scispace - formally typeset
D

David R. Greaves

Researcher at University of Oxford

Publications -  209
Citations -  19184

David R. Greaves is an academic researcher from University of Oxford. The author has contributed to research in topics: Inflammation & Chemokine. The author has an hindex of 67, co-authored 204 publications receiving 17639 citations. Previous affiliations of David R. Greaves include University of Cambridge & Netherlands Cancer Institute.

Papers
More filters
Journal ArticleDOI

A new class of membrane-bound chemokine with a CX3C motif

TL;DR: The structure, biochemical features, tissue distribution and chromosomal localization of CX3C chemokine all indicate that it represents a unique class of chemokines that may constitute part of the molecular control of leukocyte traffic at the endothelium.
Journal ArticleDOI

Position-independent, high-level expression of the human β-globin gene in transgenic mice

TL;DR: The results indicate that the DNA regions flanking the human beta-globin locus contain dominant regulatory sequences that specify position-independent expression and normally activate the complete human multigene beta- globin loci.
Journal ArticleDOI

Oxidative metabolism and PGC-1β attenuate macrophage-mediated inflammation

TL;DR: In this paper, the authors show that in response to interleukin-4 (IL-4), signal transducer and activator of transcription 6 (STAT6) and PPARgamma-coactivator-1beta (PGC-1β) induce macrophage programs for fatty acid oxidation and mitochondrial biogenesis, suggesting a potential role for metabolic therapies in treating atherogenic inflammation.
Journal ArticleDOI

Tumor necrosis factor-alpha-converting enzyme (ADAM17) mediates the cleavage and shedding of fractalkine (CX3CL1).

TL;DR: The identification of TACE as a major protease responsible for the conversion of fractalkine from a membrane-bound adhesion molecule to a soluble chemoattractant will provide new information for understanding the physiological function of this chemokine.